Today, we have a brief program, Rhythm's Commercial Readiness for Acquired Hypothalamic Obesity, an event for investors. This morning, we'll hear from Dr. David Meeker, Rhythm's Chairman, CEO and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results